Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
Sponsor: AstraZeneca
A observational or N/A phase clinical study on Bipolar Disorder, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 8 data snapshots since 2008. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Mar 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Adana, Turkey (Türkiye) , Afyonkarahisar, Turkey (Türkiye) , Ankara, Turkey (Türkiye) , Antalya, Turkey (Türkiye) , Aydin, Turkey (Türkiye) , Batman, Turkey (Türkiye) , Denizli, Turkey (Türkiye) , Erzincan, Turkey (Türkiye) , Eskişehir, Turkey (Türkiye) , Istanbul, Turkey (Türkiye) and 9 more locations